Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous System
Top Cited Papers
Open Access
- 31 August 2004
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 10 (2), 302-317
- https://doi.org/10.1016/j.ymthe.2004.05.024
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Recombinant AAV-mediated gene delivery to the central nervous systemThe Journal of Gene Medicine, 2004
- Use of adeno-associated viral vector for delivery of small interfering RNAOncogene, 2003
- Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectorsGene Therapy, 2003
- Uniform Long-Term Gene Expression using Adeno-Associated Virus (AAV) by Ex Vivo Recirculation in Rat-Cardiac IsograftsThe Thoracic and Cardiovascular Surgeon, 2002
- CMV-β-Actin Promoter Directs Higher Expression from an Adeno-Associated Viral Vector in the Liver than the Cytomegalovirus or Elongation Factor 1α Promoter and Results in Therapeutic Levels of Human Factor X in MiceHuman Gene Therapy, 2001
- Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's DiseaseExperimental Neurology, 1999
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of ExpressionHuman Gene Therapy, 1999
- Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in BrainHuman Gene Therapy, 1998
- Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus VectorsExperimental Neurology, 1998